Life healthcare is challenging a 6 year old bear channel on the news of the possible FDA approval of Biogen's Alzheimer's drug. Could be a significant for LCH's NeuraCeq Alzheimer tracer used for diagnosis. Share up strongly and very volatile today. I would wait for a break of the bear channel before entering the share. Anything before that would be pure speculation.
Order cancelled
Biogen drug not approved. The reason this was speculation right off the bat. Would have been nice if that channel broke.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.